Q1 2021 Holdings
Filed 2021-05-17 | 2 holdings | $323.1K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2021-11-15) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atea Pharmaceuticals(AVIR) | Common Stock | 04683R106 | $52.3M | 847,208 | 73.7% |
| Arcutis Biothereapeutics(ARQT) | Common Stock | 03969K108 | $18.0M | 623,836 | 25.4% |
| Nuvation Bio(NUVB)A | Common Stock | 67080N101 | $294.8K | 28,212,376 | 91.3% |
| Replimune Group(REPL) | Common Stock | 76029N106 | $152.8K | 5,008,245 | 0.2% |
| Morphic Holding | Common Stock | 61775R105 | $143.8K | 2,272,478 | 0.2% |
| Kronos Bio(KRON1USD) | Common Stock | 50107A104 | $111.8K | 3,818,283 | 0.2% |
| Ikena Oncology | Common Stock | 45175G108 | $63.5K | 2,249,123 | 0.1% |
| Spruce Biosciences | Common Stock | 85209E109 | $35.9K | 2,161,022 | 0.1% |
| Gossamer Bio(GOSS) | Common Stock | 38341P102 | $30.7K | 3,320,608 | 0.0% |
| Immunic(IMUX) | Common Stock | 4525EP101 | $28.5K | 1,788,160 | 0.0% |
| Sana Biotechnology, Inc.(SANA)A | Common Stock | 799566104 | $28.2K | 843,750 | 8.7% |
| Paratek Pharmaceuticals | Common Stock | 699374302 | $18.4K | 2,600,410 | 0.0% |
| Checkmate Pharmaceuticals | Common Stock | 162818108 | $16.2K | 1,335,050 | 0.0% |
| Alpine Immune Sciences(NVLSEUR) | Common Stock | 02083G100 | $13.6K | 1,284,900 | 0.0% |
| Syros Pharmaceuticals | Common Stock | 87184Q107 | $11.7K | 1,562,500 | 0.0% |
| Essa Pharma(EPIEUR) | Common Stock | 29668H708 | $9.8K | 336,869 | 0.0% |
| Cidara Therapeutics | Common Stock | 171757107 | $5.3K | 2,005,249 | 0.0% |
| Omega Alpha Spac | Class A ordinary shares | G6749V107 | $5.0K | 501,000 | 0.0% |
| FibroGen(FGENEUR) | Common Stock | 31572Q808 | $4.5K | 130,646 | 0.0% |
| Trevi Therapeutics(TRVI) | Common Stock | 89532M101 | $3.4K | 1,263,408 | 0.0% |
| ObsEva | Common Stock | H5861P103 | $3.2K | 999,364 | 0.0% |
| Jounce Therapeutics(JNCEEUR) | Common Stock | 481116101 | $2.8K | 275,513 | 0.0% |
| Immunocore Holdings(IMCR) | Common Stock | 45258D105 | $2.2K | 51,535 | 0.0% |
| Pieris Pharmaceuticals | Common Stock | 720795103 | $580 | 225,741 | 0.0% |